ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000194.1|Actinorhodin_1 # 1 # 441 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.685	BGC0000194.1|Actinorhodin_1 	1	441	-	Loose	950	25.409	fusH	37.84	3003026	protein homolog model	n/a	n/a	fusidane antibiotic	antibiotic inactivation	fusidic acid inactivation enzyme	ATGACCATCACCGCGCTTCCCACCGGCCTGTACGCCGAGGTCCTGTCGTTCTACGGCCACCAGATGCAGAAGCTGGACGGCCGTGACTTCGCCGGCTACGCCGCGACCTTCACCGAGGACGGCGAGTTCAGGCACTCGCCCTCGCTGCCTGCCGCCCACACCCGTGCCGGGATCACCGCCGTCCTGGAGGACTTCCACCGCAAGTTCGACGCCCGCAAAATCCAGCGCAGGCACTGGTTCGACCACACGGCGCTGAGCCAGGCGTCCGACGGCTCGATCACGGCGACCAGCTACTGCCTGGTGCTCACCGTCCACGCCGACGTCAAGGCGCCGGAGTTCGGGCCGAGTTGCCTCGTGCACGACGTCCTGGTCCGGGGGGCGGACGGCGAGTTGCTGCTGCGCTCCCGCCACGTCACCCATGACCACGTCTTCCCGGCCTGA	MTITALPTGLYAEVLSFYGHQMQKLDGRDFAGYAATFTEDGEFRHSPSLPAAHTRAGITAVLEDFHRKFDARKIQRRHWFDHTALSQASDGSITATSYCLVLTVHADVKAPEFGPSCLVHDVLVRGADGELLLRSRHVTHDHVFPA	MLNKGIRTRRARGALAGGTVLTAAAALLTAVPAAQAISGEPPAATDHAFTARLHIGEGDTLRGCSAALVHQQWLLTATSCFAATPGGEVKSGKPALKSTATLGGKTLGIVEVVPRDDRDVAMVRLAEPVTTVEPVRLAADAPVAAETLLGAGFGRTRTEWAPDQLHTGEFRVDSVTGTTVELTGQDGVSVCKGDTGGPALRGTGGEVELAAVHSRSWQGGCFGETETRTGAVDARADGLADWVTDVRNRDRTQSADVDGDGRADLVVLRSNGDVVVHRNLGDSFAAGRVMSGGWGLFVTWKDLGRLYFADVDGDRKADMIVHTSDGNIEVRFNHGTYWDQGTHWSGGWGRFIDGSDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVTWKDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVDGSDLGSLEFGDATGDGKADLLVRTKDGKVALRTNHGTYWDQGKFMITL	28.68	gnl|BL_ORD_ID|65|hsp_num:0	75			1386	1497	fusidic acid
BGC0000194.1|Actinorhodin_2 # 515 # 1438 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.722	BGC0000194.1|Actinorhodin_2 	515	1438	+	Loose	750	26.5646	tet(X6)	37.5	3005056	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGAGCACCGTGACAGTGATCGGGGCGGGCACGATCGGCCTGGGATGGATCAACCTGTTCAGCGCCCGCGGGCTGACCGTACGCGTCAACAGCCGTCGGCCCGACGTCCGGCGCGTCGTGCACGAGGCGCTCGAGCTGTTCTCCCCGGGGCGGGTGGACGAGCTGGCGGCGCGCATCGAGTACGAGCCGGACGTCGGCCGGGCGGTGGCCGGGGCGGACGTCGTCTCCGAGAACGCCCCCGACGACCTGCCGCTCAAGCAGCGGTTGTTCGCAGAGATCGGAGCGGCCGCCCCGGACCACGCCCTCGTGCTGTCCTCGACGTCGAAGCTGCTTCCCGACGAGCTGAGTCGGGACATGCCGGGACCGGGCCGGCTGGTCGTCGCGCATCCGTTCAACCCACCGCACATCGTTCCGCTGGTCGAGGTGGTCCGCGGCGAGCGCACCGACCCGGAGGCCGTCGAACGGACACTGGCCTTCCTGGCGTCGGTCGGGCGGACCCCCGTCGTGGTGCGCAGGGCGCTGCCCGGCTTCGCGGCCAACCGGCTGCAGTCGGCGCTGCTGCGCGAGAGCATCCACCTCGTCCTCGAAGGCGTGGTGACCGTCGAGGAGCTCGACCGGATCGTCACCGACTCGATCGGCCTGCGCTGGTCCACCATCGGGCCGTTCCACGCGTTCCACCTGGGCGGCGGTCCCGGCGGCCTGCGCAAGTGGCTCGAGCACCTCGGCAGCGGCCTCGAACAGGGCTGGCGTGGGCTCGGACAGCCCGCCCTCACCCCGCAGGCCGTCGAGGCTCTGGTCGCACAGACCGAAGCCGCCTACGGACACCGGCCCTACGCCGAACTGGTCCGGGACCGTGACGACCGGCACCTCGCCGTACTGGCCGCCCTGGAGCGGACCGAGCAGCCCCAGGAGGAGACCAAGTGA	MSTVTVIGAGTIGLGWINLFSARGLTVRVNSRRPDVRRVVHEALELFSPGRVDELAARIEYEPDVGRAVAGADVVSENAPDDLPLKQRLFAEIGAAAPDHALVLSSTSKLLPDELSRDMPGPGRLVVAHPFNPPHIVPLVEVVRGERTDPEAVERTLAFLASVGRTPVVVRRALPGFAANRLQSALLRESIHLVLEGVVTVEELDRIVTDSIGLRWSTIGPFHAFHLGGGPGGLRKWLEHLGSGLEQGWRGLGQPALTPQAVEALVAQTEAAYGHRPYAELVRDRDDRHLAVLAALERTEQPQEETK	MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL	81.22	gnl|BL_ORD_ID|4802|hsp_num:0	3797			24	120	tetracycline; minocycline; oxytetracycline
BGC0000194.1|Actinorhodin_4 # 2491 # 3135 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.688	BGC0000194.1|Actinorhodin_4 	2491	3135	+	Loose	200	26.1794	vanX gene in vanM cluster	28.57	3002953	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	ATGACCTCGTCGCTGCACCACGCGATACGTCTGACCACCGCGTCCGCCATCGCCCTGGGCGGACTCGTGACCCTGGGGACCAGCGCGCACGCCGCGAGCGTCGCCGTGCCGTACGAGTGCCGCACCTGGGTGCAGGGCAACACGCACCCGGTCTACGACTACGCGCGCGGCTTCGACGTCAGCGTGCCCGCCTCGGTCCGCGCGGGCAAGAAGTTCAAGGCCACCTACGATCCCGACCCGATCACCGCCTTCGCCGAGTACAACCAGATCGTCAACGACGTGCGGATCGCCTACCGGATCCCGGACGGCGCGAAGGTCCACAAGGTGCGGCTCACCGGCGGCAGCGGTCTCGGCGACTCCGACGTCCGGGTCCAGGTCAAGGGCCGGGACATCGTCGTCAGCGCCTCCGGCCCCTTCCAGGGCGGTGTCGAGTTCGACCTGCCGACGCTGAAGGTCACCTACAAGGCGCCGAAGACCACCGGCCCGCTCAACTTCGTCTCGGGCGGCTCGGGTTACGAGGACCCCGGCTTCTACTGGTACCGCTACCAGCCGATCCTGGACGAGTGGGGCCCCTTCGAGTGCTTCCCCGACCCGGCGAAGCCCGAGGCCGTCCTGGCCAGCACCCAGGTCAAGAAGCACAAGTAG	MTSSLHHAIRLTTASAIALGGLVTLGTSAHAASVAVPYECRTWVQGNTHPVYDYARGFDVSVPASVRAGKKFKATYDPDPITAFAEYNQIVNDVRIAYRIPDGAKVHKVRLTGGSGLGDSDVRVQVKGRDIVVSASGPFQGGVEFDLPTLKVTYKAPKTTGPLNFVSGGSGYEDPGFYWYRYQPILDEWGPFECFPDPAKPEAVLASTQVKKHK	MEKGFTFLDEILNDVRWDAKYATWDNFTGKPIDGYEVNRIIGTYELADALLKVQELAFNQGYGLLLWDGYRPQQAVNCFLQWAAQPEDNRTKAKYYPNIDRTEMVSKGYVASKSSHSRGSAIDLTLYRLDTDELVPMGSGFDFMDERSHHEAKGITSNEAQNRRFLRSIMENSGFEAYSFEWWHYVLINEPYPYSCFDFPVK	105.94	gnl|BL_ORD_ID|1951|hsp_num:0	1996			462	606	vancomycin; teicoplanin
BGC0000194.1|Actinorhodin_5 # 3169 # 4089 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.748	BGC0000194.1|Actinorhodin_5 	3169	4089	+	Loose	660	63.1586	MexS	26.96	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCAAGGCCGTAGCCATCCACCAGTTCGGCGGGCCGGACGTACTGGGCCTCGTCGATGTCCCCGAGCCGGTGCCGGGACCGGGCCAGGTGACCGTCCGAGTGCGGGCCGCCGGAGTCAACGGGTTCGACTGCCGGGTGCGCTCCGGCGGCATGCGCGGTCGCTATCCGGTCGAGTTCCCGCAGATCATCGGCAACGAGTTCGCCGGGGTCGTCGAGCGGACCGGACCGGAGGCGACCGGGTTCGCGCCCGGCGACGAGGTGCTCGGGTTCGCCGTGCTTCAGTCCGGCACCGAGCTGCTCGCCGTCGGCGCGGACCAGATCACCGTGAAACCGCCGGAGCTGTCGTGGGAGGTCGCGGGATCCCTCTCGGCCGTCGGACAGACCGCCGACATCGCCCTGGCCGAACTGCGGGTCGGCCCCGGGGACACCGTGCTCGTGCACGCCGCGGCCGGCGGCGTCGGCAGCCTCGCCGTCCAGCTCGTCCGGGAGCGGGGCGGCACGGCGATCGGCAGCGCCGGCGAGCACAACCACGACTACCTGCGGTCGTTGGGCGCACTGCCCGTCGCCTACGGCCCGGGCTTCGCCGACCGGGTGCGGGCCCTGGCCCCGAACGGCGTCGACGCCGCCCTCGACTGCCACGGCGGACCGGAAGCCCTCGCCGTGTCGCTCGAACTCGTCGCGGACCGGGCCCGGATCGCCACCGTCGCCAACTTCCGCGCCGCGGCCCAGGAGGGCATCGTCATGCCACGGGTGGTGCGGTCCGCCGAGCGGCTCGCCGCGCTGGCCGCACTCTGCGCCGAGGGCCGGCTGCGGCCGCACGTCGAGGCCGTCCTGCCCTTCGCCAAGGCGGCCGAGGCCCATCACCGGCTGGAGCAGGGCCATGTCCGGGGCAAGCTCGTCCTGGTGCCGGACCTGTGA	MPKAVAIHQFGGPDVLGLVDVPEPVPGPGQVTVRVRAAGVNGFDCRVRSGGMRGRYPVEFPQIIGNEFAGVVERTGPEATGFAPGDEVLGFAVLQSGTELLAVGADQITVKPPELSWEVAGSLSAVGQTADIALAELRVGPGDTVLVHAAAGGVGSLAVQLVRERGGTAIGSAGEHNHDYLRSLGALPVAYGPGFADRVRALAPNGVDAALDCHGGPEALAVSLELVADRARIATVANFRAAAQEGIVMPRVVRSAERLAALAALCAEGRLRPHVEAVLPFAKAAEAHHRLEQGHVRGKLVLVPDL	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	90.27	gnl|BL_ORD_ID|1039|hsp_num:0	1041			0	1005	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000194.1|Actinorhodin_6 # 4086 # 5687 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0000194.1|Actinorhodin_6 	4086	5687	+	Loose	600	216.468	Acinetobacter baumannii AmvA	30.06	3004577	protein homolog model	n/a	n/a	macrolide antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACGGCGAACCCCGGCCGTCCGGGCGGCCCGGCGGACCAGGGCCACCCGCGCCGCTGGGCCATCCTCGGGGTGCTGGTCCTCAGCCTGGTCGGCATCATCCTCGACAACACCGTGCTCAACGTGACGCTGCGCACCCTCACCGACCCCGAGCAGGGCCTGGGCGCCTCGCACAGCCAGGTGGAATGGGTGCTCAGCGCCTACACCCTGGCCTTCGCGGCGACGCTGTTCACCTGGGGAGTGCTGGGCGACCGACTGGGCCGCAGGCGGGTACTCCTGCTGGGCCTCGGCCTGTTCGGACTGTCGTCCCTGGCCGGGGCCTACGCCGGGTCGCCGGAGCAGCTCATCGCCGCCCGTGCCTGCATGGGGGTGAGCGGCGCGGCGGTGCTGCCGAGCACACTCGCCACCATCGCCGCCGTCTTCCCGCTGCGCGAGCGGCCCAAGGCCCTCGGGATCTGGGCGGCCTCGGTCGGCTTCGCCCTCGGCATCGGGCCCGTCACCGGCGGGATACTGCTCGCGCACTTCTGGTGGGGCTCGGTCCTGCTGGTCAACGTGCCCCTCATGGCCGGGTGCCTGGTCGCGGTGGTGCTGGTGGTGCCCGAGACCCGGGGCACGGCGGGCAGGCGCGTCGACGCGGCCGGACTGCTGCTCTCGATCGCGGGTGTCGTGCCGCTCGTCTACGCGATCATCGAGGCCGGCCGGAGCGGCGGGGTCACCCGGCCCGCGGTCTGGGCAGCCGGCCTGGCGGGCCTCGGCCTGCTCCTCGTGTTCCTGTGGCACGAGCGCCGTACCCCGGAACCCTCGCTGGAGCTCGGCTTCTTCCGGATGAAGGCCTTCTCCACCGCCGTCGCGGCCGTCGGCTTCGTCAGCTTCGCGATGATGGGCTTCCTCTTCTTCAGCGCCTTCTACCTGCAGAGCGTGCGCGGCTACACACCCCTGCAGGCCGGGGGATGCACCGTGGCACTGGCCGTCGCGAACGTGGTCTGCGGACCGCTCAGCACGGTCCTGGTGCGTTCGATCGGCCCCCGGAACGTGTGCGCGGCGGGCATGCTGGCCGTCACCGCATCGCTCTGCGGGGTCACCTTCGTGACCCAGCACGCACCCGTATGGCTGATCCTCGTCCTGTTCGCCGCGCTGGGGGCGGGCGTAGCATGCGTCATGCCGACCGCGGCCGTGTCCATCATGAACGCGATCCCACGCGAGAAGGCGGGCGTCGCCTCGGCGATGAACAACACCGTGCGCCAGCTGGGCGGCGCCCTGGGCGTCGCGGTGCTCGGTTCCCTCATGGGCGCCGCGTACCGCCGCGGCATCGAGGACGAGCTCGCCGTACTGCCGCCCTCCGCGCGGCACCAGGCCGGCGAGTCCCTGGATGCCACCCTGCTGGCCGCGACTAGGCTGGGGGAGAGCGGACTTGTCGGCCCCGCGCGCCAGGCATTCCTGGACGCCATGCACCTGGCCGCCGGGGCCGCTGCCGCGGTGGCGCTCGTGGGGGCCCTTGCCGTGCTCCGCTGGCTGCCCTCCTCCGTCACGACTCCGACGCCCCCGGCAGGGGCCGTGCCCGGCCGGGAGCATTCCGATCACCTCAAGGTCCAAGGAAGCTGA	MTANPGRPGGPADQGHPRRWAILGVLVLSLVGIILDNTVLNVTLRTLTDPEQGLGASHSQVEWVLSAYTLAFAATLFTWGVLGDRLGRRRVLLLGLGLFGLSSLAGAYAGSPEQLIAARACMGVSGAAVLPSTLATIAAVFPLRERPKALGIWAASVGFALGIGPVTGGILLAHFWWGSVLLVNVPLMAGCLVAVVLVVPETRGTAGRRVDAAGLLLSIAGVVPLVYAIIEAGRSGGVTRPAVWAAGLAGLGLLLVFLWHERRTPEPSLELGFFRMKAFSTAVAAVGFVSFAMMGFLFFSAFYLQSVRGYTPLQAGGCTVALAVANVVCGPLSTVLVRSIGPRNVCAAGMLAVTASLCGVTFVTQHAPVWLILVLFAALGAGVACVMPTAAVSIMNAIPREKAGVASAMNNTVRQLGGALGVAVLGSLMGAAYRRGIEDELAVLPPSARHQAGESLDATLLAATRLGESGLVGPARQAFLDAMHLAAGAAAAVALVGALAVLRWLPSSVTTPTPPAGAVPGREHSDHLKVQGS	MQKKWLILTIIVLIYLPVTIDATVMHVATPSLSAALNLTANQLLWIIDIYSLIMAGLILPMGALGDRIGFKKLLFIGTAVFGVGSLAAAFSPTAYALIASRAILGLGAAMLIPATLSGIRNAFTEEKQRNFALGIWSTVGGGGAAFGPLVGGFVLEHFHWGAVFLINIPIILAVLVMIVMIIPKQQEKTDQPINLGQALVLVVAILSLIYSIKSAMYNFSVLTVVMFVVGISTLIHFIRSQKRATTPMIDLELFKHPVISTSIVMAVVSMIALVGFELLLSQELQFVHGFSPLQAAMFIIPFMIAISLGGPLAGICLNKWGLRRVSSLGILVSALSLWGLAQLNFSTDHFLAWTCMVFLGFSIEIALLASTAAIMSSVPPQKASAAGAIEGMAYELGAGLGVAIFGLMLSWFYSRSIILPAELPSNLIEKASISIGETMQLASNLENPLGGQLIVVAQQAFSYAHSWVLTLSAICFFLLTVFVWFSFPKKVN	108.33	gnl|BL_ORD_ID|2718|hsp_num:0	3280			6	1383	erythromycin; acriflavine
BGC0000194.1|Actinorhodin_7 # 5689 # 6084 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.684	BGC0000194.1|Actinorhodin_7 	5689	6084	+	Loose	150	30.4166	nimG	30.12	3007109	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic inactivation	nitroimidazole reductase	ATGCCTTTCACTCCTGACGAGCTCGAGTACTACGCCTCCCAGAACCTCGGCCGGCTGGCCACCGTGGCGCCCGACGGCCAGCCCCAGGCCAACCCGGTCTCGTTCCGCGTCAACACCGAGACCGGCACGATCGACATCGGCGGGCACAACCTGACCGCCAGCAAGAAGTTCCGCAACGTCACCAAGCACGACCAGGTCGCCTTCGTCGTCGACGACCTGATCTCCACGCAGCCGTGGAACGTACGCGGTATCGAAGTGCGCGGCCGGGCCGAGGCGCTGACCGACGCGCAGCCGCCGCACCCCTACTTCGGTACCGCGATGATCCGTATCCACCCCAAGCGCATCATCACCTGGGGCCTCGGCGGCGACGCCGCCCAGCGCGGCCGCGACGTCTGA	MPFTPDELEYYASQNLGRLATVAPDGQPQANPVSFRVNTETGTIDIGGHNLTASKKFRNVTKHDQVAFVVDDLISTQPWNVRGIEVRGRAEALTDAQPPHPYFGTAMIRIHPKRIITWGLGGDAAQRGRDV	MFREMRRKRQLLSTKESVAILERMTNGTLALHGDDGYPYAVPVSYVYADGKIYFHSAMKGHKVDAISRNDKISFCVVEQDDIKPSEFTTYFRSVIVFGKARILTDEGEKRVALGLLADKYSHGEAGMEAEIAKGFNHLLMVEITVEHMTGKESIELIKERNDCS	79.88	gnl|BL_ORD_ID|4786|hsp_num:0	5782			78	315	metronidazole
BGC0000194.1|Actinorhodin_8 # 6179 # 7024 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=8bp;gc_cont=0.745	BGC0000194.1|Actinorhodin_8 	6179	7024	+	Loose	500	29.6462	TEM-196	42.86	3001376	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	ATGAGTACAGAGATCTTCCATGAGGAGTTCGCCGGGGGGCTGGTGACCGAGGGGCCGGGCGCGCCGTGGCGGCTTCGCCCGGTCGACGGTCTCGAGGCGGGAGACGGGCTGGTCCGCGGGGGACCGGACGGCCTGGTGGTCGTGCCGAGCGCCGCCCACCCGGGGACCCGGCGGCCGGCGTTCACCGAGCCCAAGCCCGGGCCGGACGGCACCCCGCTGCATCTGCGGTGGGGTGCCTTCACCACCGGCGGCACCACCGGCGGCACCGCCGGCGCGCGGGCGGCGTTCACCGCCGTGCCCGGCGAACGGCTCTCGGTCAGGGCCGAGATGGGGCTGCGCGGCTTCGGTCTGCGCTCCCATCCGTACGACGACGTGACCGAACCCGACGCGGACGCCCGGCTCGGCGCGGGCGGTCTGATCTCGGTCGATCTCGAGTCCGGGATCATCTTCGACTTCTTCCTCACACACAGCCGGCTCTACGCGGTCTACGAGCGGCTCGCGCTGCGGCCGGACGCCGAGTTCGCGGCCTTCACCTACTGCGTCCCGGTCGCGGACCGCACCCCCGGCACGCTCCACCGGCTCGAGGTCGGATACGACGTCGCGGCCGGCACCGCCCACTGGACGGCCGACGGGCAGGAGGTCCTGTCCGTGGACCGGATCGGCTTCCGCGCACTGGACGCGCGCTGGCTCCGGCGGGACAACGGCGGCCGCGAGGAGGCCGTACGGCCGCGCGGACTCAGCTTCGGCCTCGGGCTCTTCCTGGAGCGCCACTTCGGCCAGGGGGTGCGGCTGTCGGTGCGAAGGCTGTCGGTGCTCACCTCGCCCGCCGGCTCCCGCGACTCGTGA	MSTEIFHEEFAGGLVTEGPGAPWRLRPVDGLEAGDGLVRGGPDGLVVVPSAAHPGTRRPAFTEPKPGPDGTPLHLRWGAFTTGGTTGGTAGARAAFTAVPGERLSVRAEMGLRGFGLRSHPYDDVTEPDADARLGAGGLISVDLESGIIFDFFLTHSRLYAVYERLALRPDAEFAAFTYCVPVADRTPGTLHRLEVGYDVAAGTAHWTADGQEVLSVDRIGFRALDARWLRRDNGGREEAVRPRGLSFGLGLFLERHFGQGVRLSVRRLSVLTSPAGSRDS	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKIFESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	98.25	gnl|BL_ORD_ID|1901|hsp_num:0	2064			66	192	ampicillin
BGC0000194.1|Actinorhodin_10 # 7930 # 9075 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=8bp;gc_cont=0.738	BGC0000194.1|Actinorhodin_10 	7930	9075	+	Loose	900	25.7942	adeH	36.67	3000779	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCGAGGACACGATGACCCAGGAGCGGCCGTCCCTGACGGCACACGCCCGCCGGATCGCCGAACTCGCCGGGAAGCGGGCGGCCGACGCCGAACAGCAGCGCCGGCTGAGCCCCGACGTCGTCGACGCGGTCCTTCGAGCCGGTTTCGCCGCCCACTTCGTACCGGTGGCGCACGGCGGCCGGGCCGCGACGTTCGGGGAGCTGGTGGAGCCCGTCGCGGTGCTCGGCGAGGCCTGTGCCTCGACCGCCTGGTACGCCTCGCTCACGGCGAGCCTCGGCCGGATGGCCGCCTACCTGCCGGACGAGGGCCAGGCCGAGCTGTGGTCCGACGGCCCCGACGCCCTGATCGTCGGTGCCCTGATGCCGCTGGGCCGGGCCGAGAAGACCCCGGGCGGCTGGCACGTGTCGGGCACCTGGCCGTTCGTCAGCGTCGTGGATCACTCCGACTGGGCGCTGATCTGCGCCAAGGTCGGCGAGGAGCCGTGGTTCTTCGCGGTGCCGCGACAGGAGTACGGGATCGTCGACAGCTGGTACCCGATGGGTATGCGCGGAACGGGCAGCAACACGCTCGTCCTCGACGGGGTGTTCGTGCCGGATGCGCGGGCCTGCACCCGTGCGGCCATCGCGGCAGGTCTCGGTCCGGATGCCGAGGCGATCTGTCACACCGTGCCCATGAGGGCGGTCAACGGGCTGGCCTTCGCACTGCCGATGCTCGGCGCGGCCCGCGGGGCCGCGGCCGTGTGGACCTCGTGGACCGCCGGAAGACTGGCCGGGCCGACCGGGCAGAACGCCGTCTCGTCCCAGGACCGCGTGGTGTACGAGCACACGCTGGCCCGGGCCACGGGTGAGATCGACGCGGCCCAGCTGCTGTTGGAGCGGGTCGCGGCGGTCGCCGACGCCGGCTCGGCGACCGGCGTACTGGTCGGCCGCGGGGCGCGGGACTGCGCCCTGGCGGCGGAGCTGCTGACCGCCGCGACCGACCGGCTGTTCGCCTCGGCGGGCACCCGGGCACAGGCCCAGGACAGCCCGATGCAGCGCCTGTGGCGCGATGTGCACGCGGCGGGCAGCCATATCGGGCTGCAGTTCGGGCCCGGGGCGGCGCTGTACGCCGGAGAGCTGTTGAGGAGGAGCAACGATGGCTGA	MSEDTMTQERPSLTAHARRIAELAGKRAADAEQQRRLSPDVVDAVLRAGFAAHFVPVAHGGRAATFGELVEPVAVLGEACASTAWYASLTASLGRMAAYLPDEGQAELWSDGPDALIVGALMPLGRAEKTPGGWHVSGTWPFVSVVDHSDWALICAKVGEEPWFFAVPRQEYGIVDSWYPMGMRGTGSNTLVLDGVFVPDARACTRAAIAAGLGPDAEAICHTVPMRAVNGLAFALPMLGAARGAAAVWTSWTAGRLAGPTGQNAVSSQDRVVYEHTLARATGEIDAAQLLLERVAAVADAGSATGVLVGRGARDCALAAELLTAATDRLFASAGTRAQAQDSPMQRLWRDVHAAGSHIGLQFGPGAALYAGELLRRSNDG	MVITSKQNWLLSSLMGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQLNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDDNAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYFLIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTELATAQTTALNIARNRASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNARIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAGVAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLRYREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS	78.88	gnl|BL_ORD_ID|493|hsp_num:0	542			681	861	tetracycline
BGC0000194.1|Actinorhodin_11 # 9068 # 9409 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=10bp;gc_cont=0.713	BGC0000194.1|Actinorhodin_11 	9068	9409	+	Loose	1700	23.0978	AxyY	37.5	3004144	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCTGAAGTGAACGATCCCCGGGTGGGCTTCGTCGCGGTCGTCACCTTCCCGGTGGACGGCCCCGCCACCCAGCACAAGCTGGTGGAGCTGGCCACCGGCGGGGTGCAGGAGTGGATCCGCGAGGTGCCCGGCTTCCTGTCGGCCACGTATCACGCGAGCACGGACGGGACCGCGGTCGTCAACTACGCCCAGTGGGAGAGCGAGCAGGCCTACCGGGTGAACTTCGGCGCCGACCCGCGCTCGGCGGAGCTGCGGGAGGCGCTGAGCTCGCTGCCCGGGCTCATGGGGCCGCCGAAGGCCGTGTTCATGACTCCGCGGGGGGCGATCCTGCCGTCCTGA	MAEVNDPRVGFVAVVTFPVDGPATQHKLVELATGGVQEWIREVPGFLSATYHASTDGTAVVNYAQWESEQAYRVNFGADPRSAELREALSSLPGLMGPPKAVFMTPRGAILPS	MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP	10.81	gnl|BL_ORD_ID|2411|hsp_num:0	2799			414	510	erythromycin; cefepime
BGC0000194.1|Actinorhodin_12 # 9375 # 10070 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0000194.1|Actinorhodin_12 	9375	10070	-	Loose	400	56.225	tetR	26.76	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCCCTGACCCAGGACCGGATCGTCGTCACGGCGCTCGGCATCCTCGACGCCGAGGGACTCGACGCCCTGAGCATGCGGCGGCTCGCGCAGGAGCTGAAGACCGGACACGCCTCGCTGTACGCGCACGTGGGGAACCGGGACGAGCTGCTCGACCTCGTCTTCGACATCGTGCTGACCGAGGTGGAGGTCCCGGAACCGGAACCCGGCCGCTGGGCGGAGCAGGTCAAGGAGATGTGCCGGTCGCTGCGGAGGATGTTCCTGGCCCACCGGGACCTGGCACGGATCGCGATCGACCGGGTGCCGCTGGGACCCAACGGGATGGTGGGGATGGAGCGCACCATGAACCTGCTGCGCTCCGGGGGCCTGCACGACGAACTCGCCGCCTACGGGGGCGACCTGCTGTCGACCTTCGTCACGGCGGAGGCCCTGGAGCAGTCGTCCCGCAACCCCGGAACGGAACAGGGCCGGGAGCAGGCCGGCGTGTTCGCCGACCAGCTCCACGGCTACCTGAAGTCACTGCCGGCCACCAGTTTCCCGAACCTGGTCCACCTGGCCGGCCCGATCACCTCGCTCGACTCCGACCGCCGGTTCGAGCTCGGCCTCGAGATCATCATCGCCGGCCTGCTGGCCGGGGCCGGCGAGGCCGCGGACGACCAGGTCAGGACGGCAGGATCGCCCCCCGCGGAGTCATGA	MPLTQDRIVVTALGILDAEGLDALSMRRLAQELKTGHASLYAHVGNRDELLDLVFDIVLTEVEVPEPEPGRWAEQVKEMCRSLRRMFLAHRDLARIAIDRVPLGPNGMVGMERTMNLLRSGGLHDELAAYGGDLLSTFVTAEALEQSSRNPGTEQGREQAGVFADQLHGYLKSLPATSFPNLVHLAGPITSLDSDRRFELGLEIIIAGLLAGAGEAADDQVRTAGSPPAES	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	111.06	gnl|BL_ORD_ID|442|hsp_num:0	276			12	594	tetracycline
BGC0000194.1|Actinorhodin_13 # 10193 # 12001 # 1 # ID=1_13;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.715	BGC0000194.1|Actinorhodin_13 	10193	12001	+	Loose	1050	308.531	facT	38.45	3001313	protein homolog model	n/a	n/a	elfamycin antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGACGCGACCACCGTTCCATTGTAGAACGGTGGTCGTTCGTGGACCAATAGTCGAGGACCCGGGGGACGCCATGAGTTCCGTTGAAGCCGACGAGCCGGACAGGGCCACGGCCCCGCCGTCGGCGTTACTGCCCGAGGACGGCCCCGGACCGGACGGAACCGCGGCCGGACCCCCGCCCTACGCGCGCCGTTGGGCCGCGCTGGGAGTCATCCTCGGCGCCGAGATCATGGACCTGCTCGACGGCACGGTCATGAACGTGGCCGCGCCCGCCGTCCGCGCGGACCTGGGCGGCAGCCTCAGCGTCATCCAGTGGATCACCGTCGGGTACACGCTCGCGTTCGCCGTCCTGCTCGTGGTGGGCGGCCGGCTGGGCGACATCTACGGCCGCAAGCGCATGTTCGTCGTCGGCGCCGTCGGCTTCACCGCGGCCTCCGTGCTGTGCTCGGTGGCGGCCGGTCCCGAGATGCTCACCGCGGCACGCTTCCTTCAGGGCGGGCTCGGCGCGCTGATGATTCCGCAAGGGCTCGGTCTCATCAAGCAAATGTTCCCGCCCAAGGAGACGGCGGCGGCGTTCGGCGCGTTCGGACCCGCCATCGGGCTGGGCGCCGTGCTCGGCCCGATCGTCGCCGGGTTCCTGGTCGACGCCGACCTGTTCGGCACGGGCTGGCGGTCCGTCTTCCTGATCAATCTGCCGATCGGCGTGGCCGTGATCGTCGGCGCGGTCCTGCTGCTGCCCGAGGGCAAGGCGCCCGTGCGGCCGAAGTTCGACGTCGTCGGCATGGCGCTGGTGACGTCCGGGCTCACCCTGCTCATCTTCCCGCTCGTCCAGGGGCGCGAACGCGGCTGGCCCGCCTGGGCGTTCGTGCTGATGCTGGCCGGAGCGGCCGTGCTCGTCGGCTTCGTCGCCCACGAACTGCGGCAGGAGAGGCGCGGCGGCGCCACGCTCATCGAGCTCAGCCTGCTGCGCAGGTCCCGCTACGCCGCGGGACTGGCGGTGGCACTGGTGTTCTTCACCGGCGTCTCCGGAATGTCGCTGCTGCTCGCCCTGCACCTGCAGATCGGCCTGGGCTTCAGCCCCACCAGGGCCGCGCTGACCATGACGCCCTGGTCGGTGTTCCTCGTCGTCGGCGCGATCCTGACCGGGGCGGTGCTGGGATCGAAGTTCGGCCGCAAGGCCCTGCACGGCGGGCTCGTGGTGCTGGCGCTGGGCGTGCTGATCATGCTGTTGACGATCGGCGACCAGGCCGGCGGGCTGACCAGCTGGGAGCTCGTCCCCGGTATCGCCGTTGCCGGGCTCGGCATGGGCATCATGATCGGACTGCTCTTCGACATCGCCCTGGCCGACGTCGACAAGCAGGAGGCCGGTACCGCCTCCGGCGTCCTCACCGCGGTCCAGCAGCTCGGCTTCACCGTGGGCGTCGCGGTGCTCGGGACCCTGTTCTTCGGGCTGCTCGGCTCACAGGCCACGGCGAGCGTCGACGACGGCGCGAGCCGGGCCCGCACCGAACTCGCCGCCGCCGGGGCGAGCACGACCGAGCAGGACCGGCTCCTGGCCGACCTGCGGGTGTGCCTGCGGGAATCGGCGAGTCAGCAGGACTCCGAACGGACGCCGGACAGCTGCCGAAACCTCCAGCAGGCCCGGCCGGCGGTGGCCGAGGCCACGGCGCGGGCCTGGCGGACGGCCCACACCGAGAACTTCAGCACCGCGATGGTCCGCACGCTCTGGGTGGTGATCGCACTGCTGGCGGTCTCCTTCGCGCTGGCCTTCCGGCTGCCGCCCAAGCCGCGTGAGGAAGAGGGCTTCTGA	MTRPPFHCRTVVVRGPIVEDPGDAMSSVEADEPDRATAPPSALLPEDGPGPDGTAAGPPPYARRWAALGVILGAEIMDLLDGTVMNVAAPAVRADLGGSLSVIQWITVGYTLAFAVLLVVGGRLGDIYGRKRMFVVGAVGFTAASVLCSVAAGPEMLTAARFLQGGLGALMIPQGLGLIKQMFPPKETAAAFGAFGPAIGLGAVLGPIVAGFLVDADLFGTGWRSVFLINLPIGVAVIVGAVLLLPEGKAPVRPKFDVVGMALVTSGLTLLIFPLVQGRERGWPAWAFVLMLAGAAVLVGFVAHELRQERRGGATLIELSLLRRSRYAAGLAVALVFFTGVSGMSLLLALHLQIGLGFSPTRAALTMTPWSVFLVVGAILTGAVLGSKFGRKALHGGLVVLALGVLIMLLTIGDQAGGLTSWELVPGIAVAGLGMGIMIGLLFDIALADVDKQEAGTASGVLTAVQQLGFTVGVAVLGTLFFGLLGSQATASVDDGASRARTELAAAGASTTEQDRLLADLRVCLRESASQQDSERTPDSCRNLQQARPAVAEATARAWRTAHTENFSTAMVRTLWVVIALLAVSFALAFRLPPKPREEEGF	MNKAGQAEKPAAAGPPATPETPEPDPKRWLALTVLLVATFMDLLDANIITVAIPSIQRDLGASTFAIQAMTAGYTLSFAVLLITGGRLGDIFGRKRMFLVGVGGFVLASAMCAAAPSTDLLVVARALQGLTAAVMVPQVLALIHVSFAPQEIGRVVSLYASMVGLAIVSGPLIGGALISWNPLDLGWRSIFVVNLPVGVLALVGAAKWMRESSSPHAKRLDIAGMLLIVLGLLLLMVPLTLGRELDWPVWSIVSLVAAAPVLVLFVVYERHKTAKDGSPLVTLSLFKVRAFGAGIGVQLLFSAIPAGFFLSWTLYLQAGLGWSALHTGLTAIPFSLCVPIVGGLAVRRLSPLYGRYCLLAGAVLMLAGILSYAWAADRFGTDITSWHAIPSMLLIGSGMGMLMPPLTALVLREVQPQEAGAASGIINATGQLGAALGVAVIGSLFFAALAGNAGPQAERVAPTVQSVSPRQASDLRDCATEALGQDDLAKVPDICSTLVQGADDGTRDTINGALGEIRAKTFVSTYSETLYWAAGGLVPVTALVLLLPHHRVRREEPAQ	107.69	gnl|BL_ORD_ID|1345|hsp_num:0	1469			78	1668	factumycin
BGC0000194.1|Actinorhodin_14 # 12001 # 14136 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=7bp;gc_cont=0.700	BGC0000194.1|Actinorhodin_14 	12001	14136	+	Loose	1900	40.4318	MexI	28.11	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACACGCACACTGCTGTCCTGGCCCGGCGGACGCCGGCTCAAGTGGCTGGTGCTCGCGGCCTGGATCGGTCTGCTGATCGTGCTCCAGCCGCTGGCAGGGAAGCTCGGCGACGTCGAGTCCAACGACGCCGCCGCCTGGCTCCCCGGCAATGCGGAGTCGACCGAAGTGCTCGAGCTGTCCGAGAAGTTCCAGCCGGCCGACACCAGCCCGACCGTGATCGTCTACGACCGCCCGTCCGGGATCACGGCCGCCGACGAGGCGAAGGCGCGGGCCGACGCCACGCACTTCGCGGACGGCACCGGTGTGGTGGGCGAGCCCTACGGCCCGGTGCGCTCGGACGACGGCAAGGCCCTGCGCACCGTCGTCAACGTCCACCTCGGCAAGGACGGCTGGGAGGGGCTCAACGCGGCCGCGAAGGACATGCGGGCGATCGCCCGGCCGAGCGCCCCGGACGGTCTCGGCGTCCACGTCACGGGTCCGACCGGTTACGCCGCCGATTCCGCAGAGTCCTTCAGCAGCGCCGACTTCAAGCTCACCCTGGTCACCCTCCTCATCGTCGTGACGATCCTCGTCGTCACCTATCGCAGTCCCTTGCTCTGGCTGCTGCCGATGATCTCCGCGGGCATGTCCCTGGTCATCTCGCAGGCCATCGTCTACCTGCTGGCCAAGAACGCGGGACTCACGGTCAACGCCCAGACGGCGATGATCCTCACGGTCCTGGTGCTCGGCGCGGCCACCGACTACGCGCTGTTGCTCGTCGCCCGCTACCGCGAGGAGCTGCGGCGGCACGAGGACCGGCACGAGGCCATGGCCGTGGCGCTGCGCCGGGCCGGTCCCGCCATCGTGGCCAGCGCCGCCACCGTCGCCGTCAGCATGCTCGTCCTGCTGCTGGCCGCTCTGAACTCCACCAAGGGTCTCGGCCCGGTCTGCGCCGTCGGCGTGCTGGTCGGCCTGCTGTCGATGATGACGTTGCTGCCCGCCCTGCTGGTGATCTTCGGACGCTGGGTCTTCTGGCCGGCCCGGCCGAAGCACGGTACGGAGCCCGACGTCACCCGGGGTCTGTGGTCGCGGATCGCCCGGCTGGTGTCCGGCCGTCCGCGTGCCGTCTGGGTCACCACCAGCCTGCTGCTGGGGGCGGTGGCCACGCTGGCCGTCACCCTGAACGCCGACGGCCTCCAGCAGAAGGACGGTTTCAAGACCAAGCCGGAGTCGGTGGTGGGCGAGGAGATCCTGACCCGGCACTTCCCGGCCGGCTCCGGTGAACCCATGGTCGTCATCGCCAAGGGCGCCTCGGCGGACCAGGTGCACGCAGCTCTGGAGACCGTGCCCGGCGTCATCGAGGTCGCACCACCACAGGTGAAGGACGGCCTCGCCTATGTCGAGGCGACGCTCGGCGCCGGGGCGGACTCGCCGGCGGCCATGCGTTCGGTCACCGCGGCCCGCGAGACACTCGCCCGGCTGGACGGTGCGCAGGCACGGGTGGGCGGCAGCAGCGCCGTCGTGCACGACATGCGGGAGGCGTCCAGCCGCGACCGCGGTCTGATCATTCCGGTGATCCTCGCCGTGGTGTTCTGCATCCTCGCGCTGCTGCTGCGAGCACTGGTGGCGCCGCTGCTGCTGATCGCGAGCGTGGTGCTGTCCTTCTTCACCGCGCTCGGCCTCGCCGCCCTCTTCTTCAACCACGTCTTCGACTTCGCGGGAGCCGATTCGGCCTTCCCCCTGTGGGTCTTCGTCTTCCTGGTCGCCCTGGGCGTCGACTACAACATCTTCCTCGTCACCCGGATCAAGGAGGAGAGCGACCGGCTCGGCACCCGGCAGGGCGCGCTCAAGGGCCTCACCTCGACCGGTGGCGTGATCACCGCGGCCGGGCTGGTGCTGGCCGGGACCTTCGCCGCGCTGGCCACGCTGCCGCTGGTCTTCATCGCCGAGCTCGGATTCACGGTCGCGGTGGGCGTCCTGCTCGACACCATGATCGTGCGATCGGTCCTGGTCACCGCGCTCACTCTCGATGTCGGCCGGTGGATGTGGTGGCCGCACCCGCTCGCCCGGCGCGAGGACCCTTCCGAGGACCCAGCCGTATCAGGAATGCCAGATTCTATTGATTCGGAAGCCTCGACCACTGCCTCTCGGTAA	MTRTLLSWPGGRRLKWLVLAAWIGLLIVLQPLAGKLGDVESNDAAAWLPGNAESTEVLELSEKFQPADTSPTVIVYDRPSGITAADEAKARADATHFADGTGVVGEPYGPVRSDDGKALRTVVNVHLGKDGWEGLNAAAKDMRAIARPSAPDGLGVHVTGPTGYAADSAESFSSADFKLTLVTLLIVVTILVVTYRSPLLWLLPMISAGMSLVISQAIVYLLAKNAGLTVNAQTAMILTVLVLGAATDYALLLVARYREELRRHEDRHEAMAVALRRAGPAIVASAATVAVSMLVLLLAALNSTKGLGPVCAVGVLVGLLSMMTLLPALLVIFGRWVFWPARPKHGTEPDVTRGLWSRIARLVSGRPRAVWVTTSLLLGAVATLAVTLNADGLQQKDGFKTKPESVVGEEILTRHFPAGSGEPMVVIAKGASADQVHAALETVPGVIEVAPPQVKDGLAYVEATLGAGADSPAAMRSVTAARETLARLDGAQARVGGSSAVVHDMREASSRDRGLIIPVILAVVFCILALLLRALVAPLLLIASVVLSFFTALGLAALFFNHVFDFAGADSAFPLWVFVFLVALGVDYNIFLVTRIKEESDRLGTRQGALKGLTSTGGVITAAGLVLAGTFAALATLPLVFIAELGFTVAVGVLLDTMIVRSVLVTALTLDVGRWMWWPHPLARREDPSEDPAVSGMPDSIDSEASTTASR	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	69.10	gnl|BL_ORD_ID|4683|hsp_num:0	1647			2292	3015	acriflavine; tetracycline; norfloxacin
BGC0000194.1|Actinorhodin_16 # 14301 # 15053 # 1 # ID=1_16;partial=00;start_type=TTG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.641	BGC0000194.1|Actinorhodin_16 	14301	15053	+	Loose	400	28.1054	vanR gene in vanI cluster	25.33	3003728	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	TTGGGACGTGTCCATGTAATCACCGATGCGGGATGTGTAATTCCGCTTAAATCCTCGAAGGCGACCCAGCTCCTGGTGCTGCTGCTCCTCAGGCGGCACGAGGTGGTGGGATCGGGGGTGCTCATCGAGGAGTTGTGGGCGGACCACCCGCCCCGCAGCGCCATGACGACGCTGCAGACGTACGTGTACCACACCCGCCGGCTGCTGGGGGAGCACCGGGTGACGAGCGACGACCGGGAATTGGTCCTGACCCAGCCGCCCGGCTACTTCGCCCTGATCGACGAGGACGAACTCGACGTCGCGGTCGCCGAGCGTCTGATCCGCACCGGCGGCCGGCTGCTCGAGGAGAACCGGCTCGAGGAGGCGCTCGCCTCGTTGGACGCGGGACTGGATCTCTGGCGAGGCCCGGCGCTGTCCACCGTACCGTGCGGCCGGGTGCTCGAAAGCAATATCGCGCACCTGGAAGAGCTGCGGCTTTTTGGAATGCAGCTCCGTATCGACGCGAATTGGCGGCTGGGCAGAATAGGGCCGATGATTCCGGAACTCCGGTCCCTGGTAATTTCGCATCCGCTGAACGAGACCCTGCACGCCAAACTGATGGGCGCGCTCTGTCAGATGGGCAGGCGCGCCGAGGCGCTGGAATCGTATCGGAATCTCCGGCGGATACTGTCCGACGAACTGGGGGTGGATCCGACGCCGGAAATCCAGCGTATGCACATGGAAATTCTCAACGGTGAGAAGGTGCTCGTGTAG	MGRVHVITDAGCVIPLKSSKATQLLVLLLLRRHEVVGSGVLIEELWADHPPRSAMTTLQTYVYHTRRLLGEHRVTSDDRELVLTQPPGYFALIDEDELDVAVAERLIRTGGRLLEENRLEEALASLDAGLDLWRGPALSTVPCGRVLESNIAHLEELRLFGMQLRIDANWRLGRIGPMIPELRSLVISHPLNETLHAKLMGALCQMGRRAEALESYRNLRRILSDELGVDPTPEIQRMHMEILNGEKVLV	MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVDGFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRFTKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSEELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK	107.76	gnl|BL_ORD_ID|2065|hsp_num:0	2246			396	621	vancomycin; teicoplanin
BGC0000194.1|Actinorhodin_17 # 15127 # 15912 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=7bp;gc_cont=0.700	BGC0000194.1|Actinorhodin_17 	15127	15912	-	Loose	600	26.1794	emtA	34.62	3004669	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; orthosomycin antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGGCCACGCAGGACTCCGAAGTCGCACTGGTGACGGGTGCGACCAGCGGAATCGGGCTGGAGATCGCCCGCAGGCTCGGTAAGGAGGGGTTGCGCGTGTTCGTCTGCGCGCGCGGCGAAGAAGGACTGCGGACGACGCTGAAGGAGTTGCGGGAGGCGGGCGTGGAGGCGGACGGGCGGACCTGCGACGTCCGCTCGGTCCCGGAGATCGAGGCTCTCGTGGCGGCGGTGGTCGAGCGTTACGGTCCGGTCGACGTGCTGGTGAACAACGCGGGCCGGCCCGGCGGCGGCGCCACGGCCGAACTCGCCGACGAACTCTGGCTCGATGTCGTGGAGACCAACCTCACCGGCGTGTTCCGGGTGACCAAACAGGTCCTCAAGGCGGGCGGCATGCTCGAACGGGGCACGGGCCGAATCGTCAACATCGCCTCGACCGGCGGAAAGCAGGGTGTGGTGCACGCCGCGCCCTACTCCGCCTCGAAGCACGGCGTGGTCGGCTTCACCAAGGCGCTCGGTCTCGAACTGGCGAGGACCGGCATCACGGTGAACGCCGTCTGCCCCGGATTCGTCGAGACGCCGATGGCCGCGTCCGTGCGCGAGCACTACTCGGACATCTGGGAGGTGTCGACCGAGGAGGCCTTCGACCGGATCACCGCGCGCGTGCCGATCGGCCGGTACGTGCAGCCGTCCGAGGTGGCGGAGATGGTGGCGTACCTGATCGGGCCCGGTGCGGCCGCGGTCACCGCGCAGGCGCTGAACGTCTGCGGCGGGCTGGGGAACTACTGA	MATQDSEVALVTGATSGIGLEIARRLGKEGLRVFVCARGEEGLRTTLKELREAGVEADGRTCDVRSVPEIEALVAAVVERYGPVDVLVNNAGRPGGGATAELADELWLDVVETNLTGVFRVTKQVLKAGGMLERGTGRIVNIASTGGKQGVVHAAPYSASKHGVVGFTKALGLELARTGITVNAVCPGFVETPMAASVREHYSDIWEVSTEEAFDRITARVPIGRYVQPSEVAEMVAYLIGPGAAAVTAQALNVCGGLGNY	MTLYFASVLSGLEYVLSNEINNKVSDSEIIQINRGKVFFTTAESFTCLSSLRSADHLFQVIDQFQIGPHKKHLSQVSERISQLDLEFIDHKDLFWVNASRKGKQTYSRFELAKKAMEGINKRYPDWNIGTSQNHQIEFRLDIEHHNVIFSLRLTDATFRFRNQTRRFSRASLLPSVAHAMVWLSDPESKDVFVDFCCGSGTILSERATYPANQIIGGDISEAVTKIAKSNLDDSKVQVNVWDARKLPFSTGCVDKIVTNLPFGRQISPDEDLELFNHHIMIEVCRVLKPNGRAVILSESVNQLFWEAKRLGLFCLESYPLSLKGVNPTLFVFEKQDGLRRK	76.54	gnl|BL_ORD_ID|2212|hsp_num:0	3368			759	837	evernimicin
BGC0000194.1|Actinorhodin_18 # 15954 # 17396 # 1 # ID=1_18;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0000194.1|Actinorhodin_18 	15954	17396	+	Loose	750	187.963	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	34.16	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	TTGGGCGCCCGGCTCGAGCGGCGGTCGAAGGGAGATGGGGTGCCGCTGGACGCGGCGCCGGTGGATCCGGCATCGAGGGGTCCCGTATCGGCCTTCGAGCCTCCTTCGAGCCACGGGGCCGACGATGACGACGACCACCGGACGAACGCATCGAAGGAGCTGTTCGGATTGAAGCGCAGAGTCGTCATCACGGGCGTCGGCGTCCGCGCCCCCGGCGGGAACGGCACCCGGCAGTTCTGGGAACTGCTCACCTCGGGGCGGACGGCGACGCGCCGGATCTCGTTCTTCGACCCCTCGCCCTACCGTTCACAGGTCGCGGCGGAGGCCGACTTCGACCCGGTCGCCGAGGGCTTCGGCCCGCGGGAGCTCGACCGGATGGACCGGGCCTCGCAGTTCGCCGTGGCCTGTGCCCGGGAGGCGTTCGCCGCCAGCGGGCTCGACCCGGACACCCTCGACCCCGCCCGGGTCGGGGTCAGCCTCGGCAGCGCGGTGGCAGCGGCGACCAGCCTGGAGCGCGAGTATCTGCTGCTGTCGGACTCCGGCCGTGACTGGGAGGTCGACGCGGCCTGGCTGTCCCGGCACATGTTCGACTACCTGGTGCCCAGCGTCATGCCGGCCGAGGTCGCCTGGGCGGTCGGCGCCGAGGGCCCGGTCACGATGGTCTCCACCGGCTGCACCTCGGGCCTGGACTCCGTCGGCAACGCGGTCCGGGCGATCGAGGAGGGCAGCGCCGACGTGATGTTCGCGGGAGCCGCCGACACCCCGATCACCCCGATCGTCGTCGCCTGCTTCGACGCGATCCGCGCCACGACGGCGCGCAACGACGACCCGGAGCACGCCTCGCGGCCGTTCGACGGTACGCGGGACGGCTTCGTGCTGGCCGAAGGAGCCGCGATGTTCGTCCTGGAGGACTACGACAGCGCGCTGGCCCGCGGAGCCCGCATCCACGCCGAGATCTCGGGGTACGCGACGCGCTGCAACGCGTACCACATGACGGGCCTGAAGGCCGACGGCCGCGAGATGGCCGAGACCATCCGGGTCGCCCTCGACGAGTCCCGCACGGACGCGACGGACATCGACTACATCAACGCGCACGGCTCCGGCACCCGGCAGAACGACCGCCACGAGACAGCGGCGTACAAGCGCGCCCTCGGCGAACACGCCCGGCGCACTCCGGTCAGCTCGATCAAGTCGATGGTCGGCCACTCGCTGGGCGCGATCGGCTCGCTGGAGATCGCGGCCTGCGTACTCGCCCTCGAACACGGCGTGGTGCCCCCGACCGCCAACCTGCGCACCAGCGACCCCGAGTGCGATCTCGACTACGTTCCGCTGGAGGCCAGGGAGCGGAAGCTGCGGTCCGTACTCACCGTGGGCAGCGGCTTCGGCGGCTTCCAGAGCGCGATGGTGCTGCGCGACGCCGAGACCGCGGGGGCGGCCGCATGA	MGARLERRSKGDGVPLDAAPVDPASRGPVSAFEPPSSHGADDDDDHRTNASKELFGLKRRVVITGVGVRAPGGNGTRQFWELLTSGRTATRRISFFDPSPYRSQVAAEADFDPVAEGFGPRELDRMDRASQFAVACAREAFAASGLDPDTLDPARVGVSLGSAVAAATSLEREYLLLSDSGRDWEVDAAWLSRHMFDYLVPSVMPAEVAWAVGAEGPVTMVSTGCTSGLDSVGNAVRAIEEGSADVMFAGAADTPITPIVVACFDAIRATTARNDDPEHASRPFDGTRDGFVLAEGAAMFVLEDYDSALARGARIHAEISGYATRCNAYHMTGLKADGREMAETIRVALDESRTDATDIDYINAHGSGTRQNDRHETAAYKRALGEHARRTPVSSIKSMVGHSLGAIGSLEIAACVLALEHGVVPPTANLRTSDPECDLDYVPLEARERKLRSVLTVGSGFGGFQSAMVLRDAETAGAAA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	115.38	gnl|BL_ORD_ID|1968|hsp_num:0	1943			195	1239	isoniazid
BGC0000194.1|Actinorhodin_20 # 18641 # 18901 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.697	BGC0000194.1|Actinorhodin_20 	18641	18901	+	Loose	600	22.7126	RSA2-1	47.83	3006981	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	RSA2 beta-lactamase	ATGGCAACCCTGCTGACCACCGACGATCTGCGCCGCGCCCTCGTGGAGTGCGCCGGTGAGACGGACGGGACGGACCTGTCCGGCGACTTCCTCGACCTCCGCTTCGAGGACATCGGGTACGACTCGCTCGCCCTGATGGAGACCGCGGCGCGACTCGAGAGCCGGTACGGCGTGTCCATACCCGACGACGTCGCCGGCCGCGTCGACACGCCGCGAGAGCTGCTCGACCTGATCAACGGCGCACTGGCCGAGGCGGCATGA	MATLLTTDDLRRALVECAGETDGTDLSGDFLDLRFEDIGYDSLALMETAARLESRYGVSIPDDVAGRVDTPRELLDLINGALAEAA	MANTTICRLCAVSQAGLSLGETLIKGQVMSFLRSAAIFAAVLLPLSAHAADLDQTIEALENRLDARIGVAIHDTGTGKVWGHREDERFLMNSTIKVPLCAAVLSRSDVDLSEELPVRAEDILEYAPVTEQHVGGTMTVADLCFATIDQSDNTAANLLFGRLGGPESLTTFLRSIGDDLTRSDRLEPDLNIWSAGDPRDTTTPAAMVRTLEAMLTGDALTATAREQLADWMRPGGVTGALMRPSVPHNWDVADKSGSGSNTRNLIAMLTPPDGAPIFVSLSISEAEVDFATRNAALVELSAAVVRSLHAQN	27.74	gnl|BL_ORD_ID|4568|hsp_num:0	5638			183	252	
BGC0000194.1|Actinorhodin_21 # 18898 # 19848 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.728	BGC0000194.1|Actinorhodin_21 	18898	19848	+	Loose	350	26.5646	TMB-2	25.68	3004106	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin	antibiotic inactivation	TMB beta-lactamase	ATGAGCCGGCCGGGAGAACACCGGGTGGTCCACACCCTGAGGACCCAGGCCCCGGCGCGGCGGCTCTACGAGCTGGTCGCACGCGTCGAAGACTGGCCGGCCGTCTTCGAACCCACCGTGCACGTACAGGTCCTGGAGCGCGGCCCGGGCACCGAACGCTTCCGGATCTGGGCGCGCGTGGGCGGCCGGGTGAAGACCTGGACGTCCCGCCGGACGCTGGATCCCGACACCCTGAGGGTGACGTTCCGCCAGGAGCTCACCCAGCCGCCCATCGCCTCGATGGGCGGGAGCTGGGAGTTCCGGGGCGACGGCGACGGCACCGAAGTCGTGCTGACCCACGACTTCGCCGCGGTCGACGAAGCCGCCCTGCCGGGACTGCGCGAGGCGCTGGACGCGAACAGCGGGAAGGAGCTGGCCGCGCTGGTCGCGCTGGCGGAGCGCCGGCAGCCGCCCGAGGAGCTGGTCTTCACGTTCGAGGACACGCTCCGGGTGCCGTCCGGGGACGACGCCTACGCCTTCATCGAGCGCAGCGACCTGTGGCAGGAACGGCTGCCGCACGTGCGGAAGGTGACACTCACCGAGGAGGCGGCGGGTACCGGCCCCGCCGAGACGCGGGACATGACCGTCCAGGACATGACCATGGAGACGGTGACCACCGACGGCGGTACCCACACCACCCGTTCGATCCGGCTCTGCGTCCCCGCGAGGAGCATCGTGTACAAGCAGCTCGTCCCGCCCGCCCTGCTCTCCGGGCACTGCGGCGCCTGGACCTTCGGCGAGGACACGGTCACCGCCCGCCACACCGTGGCGATCGACCCGGCCCGCGTGGAAGAGGTCCTGGGCAAAGGCGCGACCGTCGCGGACGCCCGTACCCATCTGCGCGAGGTGCTCGGTGCCAACAGCCGGGCCACGCTCCGCCACGCGGCGGCCGCCGCCGGGCCGGCGTCATGA	MSRPGEHRVVHTLRTQAPARRLYELVARVEDWPAVFEPTVHVQVLERGPGTERFRIWARVGGRVKTWTSRRTLDPDTLRVTFRQELTQPPIASMGGSWEFRGDGDGTEVVLTHDFAAVDEAALPGLREALDANSGKELAALVALAERRQPPEELVFTFEDTLRVPSGDDAYAFIERSDLWQERLPHVRKVTLTEEAAGTGPAETRDMTVQDMTMETVTTDGGTHTTRSIRLCVPARSIVYKQLVPPALLSGHCGAWTFGEDTVTARHTVAIDPARVEEVLGKGATVADARTHLREVLGANSRATLRHAAAAAGPAS	MRPFLFLIIFISHFAFANEEIPGLEVEEIDNGVFLHKSYSRVEGWGLVSSNGLVVISGGKAFIIDTPWSESDTEKLVDWIRSKKYELAGSISTHSHEDKTAGIKWLNGKSITTYASALTNEILKREGKEQARSSFKGNEFSLMDGFLEVYYPGGGHTIDNLVVWIPSSKILYGGCFIRSLEPSGLGYTGEAKIDQWPQSARNTISKYPEAKIVVPGHGKIGDFELLKHTKVLAEKASNKANHGDR	128.98	gnl|BL_ORD_ID|2394|hsp_num:0	2774			411	624	ceftazidime
BGC0000194.1|Actinorhodin_22 # 19845 # 20738 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.729	BGC0000194.1|Actinorhodin_22 	19845	20738	+	Loose	475	82.8037	cphA3	27.07	3003093	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CphA beta-lactamase	ATGACGGTCGAGGTCCGTGAGGTCGCCGAGGGTGTCTACGCCTACGAGCAGGCCCCCGGCGGCTGGTGCGTCAGCAACGCGGGCATCGTGGTGGGCGGCGACGGCGCGCTCGTCGTCGACACGCTGTCGACGATCCCGAGGGCGCGGCGGCTGGCGGAGTGGGTCGACAAGCTCGCCGCGGGCCCCGGCCGTACCGTGGTCAACACCCACTTCCACGGCGACCACGCCTTCGGCAACCAGGTCTTCGCGCCGGGGACGCGGATCATCGCGCACGAGGACATGCGGTCCGCCATGGTGACGACCGGCCTGGCCCTCACCGGGCTCTGGCCGCGGGTCGACTGGGGCGAGATCGAGCTGAGGCCGCCGAACGTGACCTTCCGCGACCGGTTGACCCTGCACGTCGGCGAGCGACAGGTCGAACTGATCTGCGTCGGCCCCGCGCACACCGATCACGACGTGGTGGTCTGGCTGCCCGAGGAGCGGGTGCTGTTCGCGGGGGACGTCGTCATGTCGGGCGTCACTCCGTTCGCCCTCTTCGGTTCGGTGGCCGGCACGCTGGCCGCGCTCGACCGGCTGGCGGAGCTGGAGCCCGAGGTGGTCGTCGGCGGGCACGGCCCGGTGGCGGGACCCGAGGTGATCGACGCCAACCGGGACTATCTGCGCTGGGTCCAGCGCCTCGCCGCCGATGCGGTCGACCGCCGGCTGACACCGTTGCAGGCCGCGCGCCGGGCGGACCTCGGCGCCTTCGCCGGGCTGCTGGACGCGGAGCGCCTCGTCGCGAACCTGCACCGGGCCCACGAGGAGCTGCTGGGCGGGCACGTGCGTGACGCCATGGCGATCTTCGCGGAGCTGGTCGCCTACAACGGTGGGCAGCTGCCCACCTGCCTCGCCTAG	MTVEVREVAEGVYAYEQAPGGWCVSNAGIVVGGDGALVVDTLSTIPRARRLAEWVDKLAAGPGRTVVNTHFHGDHAFGNQVFAPGTRIIAHEDMRSAMVTTGLALTGLWPRVDWGEIELRPPNVTFRDRLTLHVGERQVELICVGPAHTDHDVVVWLPEERVLFAGDVVMSGVTPFALFGSVAGTLAALDRLAELEPEVVVGGHGPVAGPEVIDANRDYLRWVQRLAADAVDRRLTPLQAARRADLGAFAGLLDAERLVANLHRAHEELLGGHVRDAMAIFAELVAYNGGQLPTCLA	MMKGWIKCTLAGAVVLMASFWGGSVRAAGIELKQVSGPVYVVEDNYYVKENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPELIDHYEELIKAVPQS	116.93	gnl|BL_ORD_ID|1649|hsp_num:0	1687			87	759	
BGC0000194.1|Actinorhodin_23 # 20750 # 21283 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.721	BGC0000194.1|Actinorhodin_23 	20750	21283	+	Loose	910	24.6386	smeS	53.85	3003067	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCAGCCGACCAGGGAATGCTCCGGGACGCCATGGCCCGGGTGCCGGCCGGGGTGGCGCTCGTCACCGCCCATGACCGCGGGGGAGTCCCGCACGGTTTCACCGCCAGTTCGTTCGTGTCCGTCTCGATGGAGCCGCCACTGGCACTGGTCTGCCTGGCTCGTACGGCCAACTCCTTCCCGGTGTTCGACAGTTGCGGCGAGTTCGCGGTGAGCGTGCTGCGCGAGGACCACACGGACCTGGCCATGCGCTTCGCGCGCAAGTCCGCGGACAAGTTCGCGGGCGGGGAGTTCGTCCGTACCGCGCGGGGAGCGACCGTGCTCGACGGAGCGGTCGCGGTCGTCGAGTGCACGGTCCACGAGCGCTACCCGGCGGGCGACCACATCATCCTGCTCGGCGAGGTCCAGTCCGTGCACGTCGAGGAGAAGGGCGTACCGGCGGTCTACGTGGACCGCCGGTTCGCCGCCCTGTGCTCGGCGGCGGGTGCCTGCCCGTCCGCCACCGGGCGGGGCGTGCCCGCGCATGCCGGCTGA	MAADQGMLRDAMARVPAGVALVTAHDRGGVPHGFTASSFVSVSMEPPLALVCLARTANSFPVFDSCGEFAVSVLREDHTDLAMRFARKSADKFAGGEFVRTARGATVLDGAVAVVECTVHERYPAGDHIILLGEVQSVHVEEKGVPAVYVDRRFAALCSAAGACPSATGRGVPAHAG	MAFAMAKFQLKFGLTAKTFLAIFTACLLVLAVNGIASRVAFQTGFLDYLNDQGDLRMQRLMPHLQREYREHGGWEHLHGDGDRWARLLRPDLAHGHEGPVPSLSDQTGVPSRLGLFDAQHRFVAGNPDATSDDEPHAVQVDGQTVGWLGMVPFQTVIATNDLNFYNTQVRAWWVIGIALLLVTVLLAWLVSRALRQRLAKLAAATHRLAAGDYATRIERTSDDELDALVNDFNRMAQALDDTERNRRAFIADISHELRTPLAVVRAELEAIEDGIRPLDRANLVGLQGEIRQLGKLIDDLHDLSMTQSGGLAYRFAPLDLVALLRSELNGMRVRFANAGLALEEDLPATPLQVSGDERRLQQVLANLLENALRYTHAGGRVRVQAARVPAGVQLVVEDTAPGVPPDKCALVFERFYRVESSRNRASGGSGLGLAISHNIILAHHGVIHAAPSPLGGLRVVITLPEPA	37.90	gnl|BL_ORD_ID|312|hsp_num:0	342			1134	1212	
BGC0000194.1|Actinorhodin_19 # 17393 # 18616 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.741	BGC0000194.1|Actinorhodin_19 	17393	18616	+	Loose	750	104.375	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	32.8	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAGCGTCCTCATCACCGGAGTCGGCGTCGTCGCACCCAACGGCCTCGGCCTGGCGCCGTACTGGTCGGCGGTGCTGGACGGCCGCCACGGCCTCGGCCCGGTCACCCGCTTCGACGTGAGCCGGTACCCGGCGACCCTCGCCGGCCAGATCGACGACTTCCACGCGCCGGACCACATCCCGGGCCGGTTGCTGCCGCAGACGGACCCCTCCACACGGCTCGCGCTGACCGCCGCGGACTGGGCCCTCCAGGACGCGAAGGCGGACCCGGAGTCGCTGACCGACTACGACATGGGCGTGGTGACCGCCAACGCCTGCGGTGGGTTCGACTTCACCCACCGGGAGTTCCGCAAGCTGTGGTCCGAGGGCCCCAAGTCGGTCAGCGTGTACGAGTCCTTCGCCTGGTTCTACGCGGTGAACACCGGCCAGATCTCCATCCGGCACGGTATGCGCGGTCCGAGCAGTGCCCTGGTCGCCGAGCAGGCCGGGGGCCTGGACGCCCTGGGCCACGCCCGCCGTACGATCCGCCGCGGCACGCCGCTGGTGGTCTCCGGCGGGGTGGACTCGGCACTCGACCCGTGGGGCTGGGTCTCGCAGATCGCCAGTGGCCGGATCAGCACGGCCACCGATCCGGACCGGGCGTATCTGCCCTTCGACGAGCGGGCGGCCGGCTACGTTCCGGGCGAGGGCGGGGCCATCCTCGTCCTGGAGGACAGCGCCGCGGCCGAGGCCCGCGGCCGGCACGACGCGTACGGCGAACTCGCCGGCTGCGCCTCCACCTTCGACCCCGCCCCCGGATCCGGACGGCCCGCGGGCCTGGAACGCGCGATCCGGCTGGCGCTGAACGACGCCGGGACCGGTCCCGAGGACGTCGACGTCGTGTTCGCCGACGGCGCGGGCGTGCCCGAGCTGGACGCCGCCGAGGCCCGGGCGATCGGCCGGGTGTTCGGCCGCGAAGGGGTGCCCGTCACCGTCCCCAAGACGACGACGGGCCGCCTCTACTCCGGCGGCGGCCCGCTCGACGTGGTCACCGCCCTGATGTCCCTGCGCGAAGGGGTGATCGCGCCGACCGCGGGCGTGACGTCCGTACCCCGGGAGTACGGCATCGACCTGGTGCTCGGCGAACCCCGCAGCACGGCCCCGCGCACCGCACTGGTCCTGGCCAGGGGCCGCTGGGGCTTCAACTCGGCGGCGGTCCTGCGCCGTTTCGCACCGACCCCGTAA	MSVLITGVGVVAPNGLGLAPYWSAVLDGRHGLGPVTRFDVSRYPATLAGQIDDFHAPDHIPGRLLPQTDPSTRLALTAADWALQDAKADPESLTDYDMGVVTANACGGFDFTHREFRKLWSEGPKSVSVYESFAWFYAVNTGQISIRHGMRGPSSALVAEQAGGLDALGHARRTIRRGTPLVVSGGVDSALDPWGWVSQIASGRISTATDPDRAYLPFDERAAGYVPGEGGAILVLEDSAAAEARGRHDAYGELAGCASTFDPAPGSGRPAGLERAIRLALNDAGTGPEDVDVVFADGAGVPELDAAEARAIGRVFGREGVPVTVPKTTTGRLYSGGGPLDVVTALMSLREGVIAPTAGVTSVPREYGIDLVLGEPRSTAPRTALVLARGRWGFNSAAVLRRFAPTP	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	97.84	gnl|BL_ORD_ID|1968|hsp_num:0	1943			327	1248	isoniazid
BGC0000194.1|Actinorhodin_3 # 1438 # 2424 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=10bp;gc_cont=0.749	BGC0000194.1|Actinorhodin_3 	1438	2424	+	Loose	660	120.168	MexS	30.99	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGTGCCGTGCAGTTCGACCGGTACGGGGACCCCGACGTGCTGTACGTCGCCGAGCGTCCCGTCCCCGAACCCGGCCCCGGCCAGGTGAGAATCGCCGTCGACGCCGTGAGCGTCGGCCACGCGCAGACCCAGATGCGGCGCGAGGCCTTCCCCGCGCCGATGTGGCGGCCCGTCTTCCCCGTCGTCCTCGGCGGCGACGTGGTCGGCAGGATCACCGCGGTGGGACCGGGCGTCACGGCCCTGCGGCCGGGAGACCGGGTCGGTGCGTTCACCCTCTACGGCGCCTACGCCGAGCAGGTCGTCGTCGACGCCGTCACCGTCGTACCCGTGCCCGAGGAGCTGGACGCCGCCGAGGCCGCGGTCCTCCCGGGCACCGGACTGATCGCCCTCGGCATCCTGCGGACCGGACGACTGCGCAAGGGCGAGACGGTGCTGATCCACGCGGCGGCCGGCGGGGTGGGCCACATCGCGGTCCAGCTCGCCCGGGCGGCCGGCGCCGGCCTGATCATCGGCACCGCGGGCGCGGCCGCCAAACGCGAGTTCGCCCGCGCGACGGGCGCCGACGCCGTCGTCGACCACCGCTCCGCACACTGGGCCGACGAGGTCCGGGAACTCACCGGGGGGCGTGGCCCCGACCTGATCCTGGACGGCATCGGCGCCGAGGTCCTGGAGCAGGGAGTCGGTCTGCTCGCTCCGGGCGGCCGGCTGGTGTTCTACGGCTCGTCCGGCGGCGAGCTGGCGATCCCGAAGGTGTCGGTGATGGACCTCATCGGCATCAAGTACGTCACCGGCTTCGCCCTGTCGGCCTGGCGCGGTGGCCGCCCGCAGGAGTACGAGGCGGGCGTCGCCGAACTCACCCGACTGCTGGCCGAAGGACAGGTCACGTCCGCGGTGCACGCCCGGCTGCCGCTGGAGCGGGCGGCCGAGGCGCACGCCGTCGTCGAGGCCAGGGCCCAGCTGGGCCGGGTCGTGCTCGTCCCCTGA	MRAVQFDRYGDPDVLYVAERPVPEPGPGQVRIAVDAVSVGHAQTQMRREAFPAPMWRPVFPVVLGGDVVGRITAVGPGVTALRPGDRVGAFTLYGAYAEQVVVDAVTVVPVPEELDAAEAAVLPGTGLIALGILRTGRLRKGETVLIHAAAGGVGHIAVQLARAAGAGLIIGTAGAAAKREFARATGADAVVDHRSAHWADEVRELTGGRGPDLILDGIGAEVLEQGVGLLAPGGRLVFYGSSGGELAIPKVSVMDLIGIKYVTGFALSAWRGGRPQEYEAGVAELTRLLAEGQVTSAVHARLPLERAAEAHAVVEARAQLGRVVLVP	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	96.76	gnl|BL_ORD_ID|1039|hsp_num:0	1041			6	1005	ciprofloxacin; trimethoprim; chloramphenicol
